Amlodipine Besylate/Tadalafil

苯磺酸氨氯地平/他达拉非

Report date: 2022/03/08 16:45:37

Base Information

Drug NameAmlodipine Besylate/Tadalafil
Drug Alias NameTadalafil-Amlodipine Besylate氨氯地平/他达拉非他达拉非和苯磺酸氨氯地平Tadalafil•Amlodipine BesylateTadalafil and Amlodipine Besylate +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelPhosphodiesterase 5A
Therapy Area/IndicationsHypertensionErectile Dysfunction
Global Approved IndicationsHypertensionErectile Dysfunction
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2016/05/03
Country/TerritorySouth Korea
CombinationsYes TadalafilAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionErectile Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeC02G04BE
Related LinksN/A